PFDA, a PFAS "forever chemical," can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link.
Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), often called "forever chemicals," to serious birth defects.
However, scientists have struggled to explain exactly how these pollutants affect fetal development. A new study now offers the first detailed molecular explanation, revealing how a PFAS compound known as perfluorodecanoic acid (PFDA) can cause craniofacial abnormalities before birth.
The findings were published in ACS Chemical Research in Toxicology.
"Most people are exposed to small amounts of PFAS in everyday life, but higher exposure can occur through contaminated water, living near manufacturing sites, or certain jobs like firefighting and ski waxing, which is why it's so important to understand the chemicals better," said the paper's senior author, Jed Lampe, PhD, associate professor at University of Colorado Anschutz Skaggs School of Pharmacy and Pharmaceutical Sciences.
"We wanted to understand which PFAS compounds are truly harmful during fetal development, especially for people with higher exposure, and how they cause damage."
PFDA Identified as the Most Toxic PFAS
Around 15,000 PFAS compounds are used in consumer and industrial products, but growing evidence suggests only a portion of them present major health concerns. To identify the most harmful compounds, Lampe and colleagues Michaela Hvizdak and Sylvie Kandel examined 13 commonly detected PFAS. Their results showed that PFDA was the most toxic to craniofacial development in a fetus.
The researchers found evidence linking PFDA to significant facial abnormalities seen in both people and laboratory animals. Some estimates suggest the compound may increase the risk of these defects by about 10%, even at very low exposure levels.
"This finding moves us beyond association by providing a clear explanation for how PFDA can interfere with fetal development. It's a critical step toward understanding a vast and complex class of environmental chemicals," said Lampe.
How PFDA Disrupts Retinoic Acid Signaling
The team discovered that PFDA interferes with retinoic acid, a molecule that plays a vital role in forming the face and head during early pregnancy. Retinoic acid controls the activity of hundreds of genes, and maintaining the correct amount is essential. Because a fetus cannot produce or safely remove excess retinoic acid, it depends entirely on the mother to keep levels balanced.
Researchers found that PFDA blocks CYP26A1, an enzyme responsible for breaking down excess retinoic acid. When the enzyme is inhibited, retinoic acid can accumulate to harmful levels and disrupt normal facial development. PFDA also reduces the activity of genes that produce CYP26A1 through a separate biological mechanism, creating what researchers describe as a "double hit" to a system that is critical for early development.
"As a result, severe craniofacial abnormalities can develop, including underdeveloped eyes and abnormal jaw formation, which were the most common effects of PFDA exposure during fetal development," said Lampe.
Toward Better PFAS Risk Screening and Prevention
By uncovering the biological mechanism behind these developmental abnormalities, the researchers hope to help scientists create targeted laboratory tests and computer screening tools that can rapidly assess the risks posed by different PFAS compounds. Such tools could help regulators and manufacturers identify the most hazardous chemicals, distinguish them from safer alternatives, and support the development of less toxic products.
The team also believes the findings could lead to practical strategies for people with elevated PFAS exposure, including firefighters and ski wax technicians. Future research may explore ways to reduce exposure and determine whether lowering PFDA levels during pregnancy could help protect fetal development.
Reference: "New Mechanistic Evidence for Perfluorodecanoic Acid (PFDA) Teratogenicity via CYP26A1-Mediated Retinoic Acid Metabolism and Signaling" by Michaela Hvizdak, Sylvie E. Kandel and Jed N. Lampe, 30 March 2026, Chemical Research in Toxicology.
DOI: 10.1021/acs.chemrestox.5c00468
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]
Scientists Finally Uncover How a “Forever Chemical” Causes Birth Defects
PFDA, a PFAS “forever chemical,” can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link. Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), [...]
Scientists Have Discovered These Deadly Parasites Are Secretly Swapping DNA
Leishmania parasites appear to evolve through widespread genetic exchange, reshaping assumptions about how they adapt and spread. A parasite long thought to spread mostly by cloning itself may be far more genetically dynamic than [...]
Stanford’s Revolutionary New Microscope Reveals Living Cells in Stunning Detail
Stanford researchers have developed a microscope that can show how nanostructures interact inside living cells at the highest resolution achieved so far. The view into living cells just got better. Stanford researchers have merged [...]
What Bundibugyo Ebola vaccines and treatments are under development
By Mariam Sunny and Jennifer Rigby May 29 (Reuters) – Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the [...]
Why More People in Their 30s Are Suddenly Getting Colon Cancer
A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups. Researchers in Switzerland have identified a concerning trend: while colorectal [...]
Researchers Compare MS Models to Human Tissue in Search for Better Therapies
Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve efforts to develop treatments that restore lost [...]
Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a breakthrough in personalized cancer [...]
New Vitamin B12-Based Therapy Could Change How Brain Cancer Is Treated
Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue. For decades, one of the biggest problems in brain cancer treatment has had [...]
Simple Fiber Supplement Cuts Knee Arthritis Pain in Just 6 Weeks, Study Finds
A daily inulin supplement may help reduce knee osteoarthritis pain while revealing a possible link between gut health, muscle function, and pain sensitivity. For millions of people living with knee osteoarthritis, managing chronic pain [...]
This Common Vitamin May Help Stop Prediabetes From Turning Into Diabetes
Vitamin D may help prevent type 2 diabetes in people with specific genetic variations, offering a possible path toward personalized diabetes prevention. More than 40% of U.S. adults have prediabetes, a condition in which [...]
Ebola, hantavirus: Is the world prepared for the next pandemic?
Funding cuts to health research and a growing antivaccine movement are making it harder than ever to respond to viruses. The World Health Organization (WHO) has declared that an Ebola outbreak in Uganda and [...]
May 2026 Healthcare News and Trends: Market Signals That Matter
Artificial intelligence is dominating headlines, telehealth has settled into a new normal, and digital health continues to promise transformation. However, much of what is being discussed in healthcare today reflects potential rather than reality. [...]
Scientists Rewire Donor Stem Cells To Outsmart Aggressive Blood Cancers
Researchers have tested a gene-edited stem cell transplant designed to shield healthy blood-forming cells from powerful cancer-targeting immunotherapies. For patients with highly aggressive blood cancers, stem cell transplantation can offer a rare chance at [...]
Recent Digital Health Trends, Insights and News – May 2026
Last month marked continued progress as digital health moves into its next phase — from AI expanding into drug discovery and core infrastructure to new federal pathways accelerating device access and home-based care. Together, [...]
Cancer Mystery Solved: Scientists Discover How Melanoma Becomes “Immortal”
Scientists have uncovered a previously overlooked mechanism that may help melanoma cells become effectively “immortal.” Cancer cells face a major problem before they can become deadly: They have to figure out how to stop [...]
